BOOKMARK, COMMENT, ORGANIZE, SEARCH

IT'S SIMPLE AND IT WORKS

Popular Categories

software (9410)
internet (9249)
business (8208)
online (6824)
health (6759)
free (5988)
home (5815)
news (5688)
tools (5067)
web (4913)
web2.0 (4202)
game (4149)
& (3840)
shopping (3790)
social (3616)
games (3516)
golf (3450)
default (3376)
blog (3205)
search (3120)
design (3113)
arizona (3094)
music (2909)
lasvegas (2880)
mortgage (2856)
myrtlebeach (2855)
golfswing (2852)
golfclubs (2851)
desktop (2843)
credit (2819)
windows (2726)
download (2700)
mp3 (2607)
file (2502)
management (2450)
screen (2440)
bookmarks (2395)
video (2374)
security (2321)
money (2249)
loans (2242)
loan (2223)
screensaver (2159)
utilities (2150)
email (2118)
education (2104)
image (1968)
debt (1942)
finance (1914)
to (1907)

Medicines Company: Premium Company Profile

by Bharat Book Bureau

posted in Health and Fitness : Medicine

Syndicate This Article

Medicines Company: Premium Company Profile

The Medicines Company is a pharmaceutical company that provides drugs for the treatment of diseases in the area of acute care. The company's research is focused on developing new and valuable commercially viable products acquired from other pharmaceutical innovators by using its range of clinical and commercial skills.
Scope of this report

* Contains corporate strategy, value chain presence and SWOT Analysis
* Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
* Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Research and analysis highlights

The company markets Angiomax (bivalirudin) for use in patients undergoing coronary angioplasty, a procedure to clear restricted blood flow in arteries around the heart. The company is currently evaluating Angiomax for use in additional patient populations, including, in a Phase III trial, patients presenting with acute coronary syndromes (ACS).

The Medicines Company derives majority of its revenues from the product sales of Angiomax indicated for use as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).

The company also generated revenues from license, collaboration and other during 2006 that include revenues from reimbursement of fees the company paid, for the services rendered by a research organization. During the period 2002-2006, the company's total revenues increased at a robust CAGR of 54%, from $38 million to $214 million.
Key reasons to read this report

* Access all the important information and analysis on the company in a single report
* Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
* Gain access to company's adjusted five year financial data along with key ratios and market capitalization


To know more and to buy a copy of your report to feel free to visit :
http://www.bharatbook.com/detail.asp?id=76526&rt=Medicines-Company-Premium-Company-Profile.html

Related Reports


Asia Pacifics Leading OTC Medicine Markets
http://www.bharatbook.com/detail.asp?id=77616&rt=Asia-Pacifics-Leading-OTC-Medicine-Markets.html


Americas Leading OTC Medicine Markets
http://www.bharatbook.com/detail.asp?id=77650&rt=Americas-Leading-OTC-Medicine-Markets.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook

About the Author:

Bharat Book Bureau, the leading market research information aggregator provides reports, company profiles, newsletters, country info. and online databases for the past twenty two years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our reports help global companies to know different market before starting up business / expanding in different countries across the world.

Newest Articles in Medicine

Other articles by Bharat Book Bureau